blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0535470

EP0535470 - Succinimide derivatives of 2,5-dimercapto-1,3,4-thiadiazole [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.09.1998
Database last updated on 16.09.2024
Most recent event   Tooltip03.05.2002Lapse of the patent in a contracting state
New state(s): ES
published on 19.06.2002  [2002/25]
Applicant(s)For all designated states
R.T. VANDERBILT COMPANY, INC.
30 Winfield Street Norwalk
Connecticut 06856-5150 / US
[N/P]
Former [1993/14]For all designated states
R.T. VANDERBILT COMPANY, Inc.
30 Winfield Street
Norwalk, Connecticut 06856-5150 / US
Inventor(s)01 / Karol, Thomas J.
33 Harbor View Avenue
Norwalk, Connecticut 06854 / US
[1993/14]
Representative(s)Cohausz & Florack
Patent- & Rechtsanwälte
Partnerschaftsgesellschaft mbB
Bleichstrasse 14
40211 Düsseldorf / DE
[N/P]
Former [1994/11]Cohausz & Florack Patentanwälte
Postfach 33 02 29
D-40435 Düsseldorf / DE
Former [1994/05]Cohausz & Florack Patentanwälte
Postfach 33 02 29
D-40435 Düsseldorf / DE
Former [1993/14]Redies, Bernd, Dr. rer. nat.
COHAUSZ & FLORACK Patentanwaltsbüro Postfach 33 02 29
D-40435 Düsseldorf / DE
Application number, filing date92116013.118.09.1992
[1993/14]
Priority number, dateUS1991077000002.10.1991         Original published format: US 770000
[1993/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0535470
Date:07.04.1993
Language:EN
[1993/14]
Type: B1 Patent specification 
No.:EP0535470
Date:19.11.1997
Language:EN
[1997/47]
Search report(s)(Supplementary) European search report - dispatched on:EP08.01.1993
ClassificationIPC:C07D417/12, C07D417/14, C10M135/36
[1993/14]
CPC:
C07D417/14 (EP); C10M135/36 (EP); C10M2219/10 (EP);
C10M2219/102 (EP); C10M2219/104 (EP); C10M2219/106 (EP);
C10N2050/10 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/14]
TitleGerman:Succinimidderivate von 2,5-Dimercapto-1,3,4-thiadiazol[1997/47]
English:Succinimide derivatives of 2,5-dimercapto-1,3,4-thiadiazole[1993/14]
French:Dérivés de succineimide de 2,5-dimércapto-1,3,4-thiadiazole[1993/14]
Former [1993/14]Succinimidderivate von 2,5-Dimencapto-1,3,4-Thiadiazol
Examination procedure05.05.1993Examination requested  [1993/26]
30.12.1996Despatch of communication of intention to grant (Approval: Yes)
26.02.1997Communication of intention to grant the patent
12.05.1997Fee for grant paid
12.05.1997Fee for publishing/printing paid
Opposition(s)20.08.1998No opposition filed within time limit [1998/46]
Fees paidRenewal fee
13.08.1994Renewal fee patent year 03
25.08.1995Renewal fee patent year 04
17.08.1996Renewal fee patent year 05
28.08.1997Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT19.11.1997
CH19.11.1997
DK19.11.1997
ES19.11.1997
GR19.11.1997
LI19.11.1997
PT19.02.1998
SE19.02.1998
[2002/25]
Former [2000/05]AT19.11.1997
CH19.11.1997
DK19.11.1997
GR19.11.1997
LI19.11.1997
PT19.02.1998
SE19.02.1998
Former [1998/45]AT19.11.1997
CH19.11.1997
DK19.11.1997
LI19.11.1997
PT19.02.1998
SE19.02.1998
Former [1998/37]AT19.11.1997
DK19.11.1997
PT19.02.1998
SE19.02.1998
Former [1998/35]AT19.11.1997
DK19.11.1997
SE19.02.1998
Former [1998/30]AT19.11.1997
DK19.11.1997
Documents cited:Search[AD]FR2237957  (LUBRIZOL CORP [US]);
 [A]EP0218816  (PENNWALT CORP [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.